the etiology of erythropoietic protoporphyria
Published 1 year ago • 352 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
1:45
mechanism of action of bitopertin to treat patients with epp
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:32
factors contributing to the pathogenesis of icaht
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
5:23
everything about erythropoietin (crystal clear!)
-
1:11:10
morphology session 8
-
20:12
hematopoiesis | erythropoiesis
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
0:57
the potential of the tsafinder tool in hematological oncology
-
6:04
erythropoietin
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:27
occurrence & importance of endemic variants causing attrv in different regions of the world
-
1:30
the use of pirtobrutinib in richter's transformation: data from the bruin trial
-
1:17
phase ii study of tosedostat in mds